Navigation Links
Quorum Review IRB Appoints Michael Malafronte Director of Quality and Document Administration
Date:8/18/2008

Quorum Review IRB, an AAHRPP accredited ethics review board, today announced that they have appointed Michael Malafronte to the position of Director of Quality and Document Administration. Mr. Malafronte brings to Quorum 24 years of executive experience with quality systems and operations within the pharmaceutical industry. In his position Michael will lead Quorum in continuous quality improvement.

Seattle, WA (PRWEB) August 18, 2008 -- Quorum Review IRB, an AAHRPP accredited ethics review board, today announced that they have appointed Michael Malafronte to the position of Director of Quality and Document Administration. Mr. Malafronte brings to Quorum 24 years of executive experience with quality systems and operations within the pharmaceutical industry. In his position Michael will lead Quorum in continuous quality improvement.

As the demand for increased speed in human clinical trial review, document production and delivery continues, Quorum recognizes the importance of maintaining, implementing and improving robust quality systems. Mr. Malafronte brings with him a wealth of knowledge and experience to help Quorum build upon its market leading innovations while maintaining strict adherence to outstanding regulatory compliance practices. "Mike brings to Quorum the expertise to insure that Quorum's performance remains consistent, reliable and on the cutting edge," explains Cami Gearhart, CEO.

Prior to joining Quorum Review IRB, Mr. Malafronte directed quality groups at Nastech Pharmaceuticals, ICOS Corporation, and Abbott Labs. "It is a pleasure to be heading up the Quality Management and Document Administration teams at Quorum Review," says Mr. Malafronte. "I'm very excited about the on-going work here at Quorum and the outstanding groups that I will direct. My experience managing other quality organizations in the pharmaceutical business provides me with the background necessary to meet our quality goals and deliver documents to our customers in a timely manner."

About Quorum Review
Quorum Review is an independent ethics review board that is fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) and has been providing ethics review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human research subject protection regulations, guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.    

Quorum's best-in-class service and support includes 3 protocol board meetings a week, daily amendment board meetings, 24 hour site review, 36 hour amendment review, and a secure web portal for online submissions, downloads and submission status review. Quorum can review studies in the US and Canada, review federally funded studies and has a specially designated Phase I study management team.

For information about Quorum Review services:
customerrelations@quorumreview.com
www.quorumreview.com

###

Read the full story at http://www.prweb.com/releases/institutional_review/independent_board/prweb1217544.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. SEIU Sending Team to Review Finances at Local 6434, United Long Term Care Workers Union
2. Novel Diagnostic Marker for Acute Kidney Injury Previewed at Abbott-Sponsored Scientific Workshop
3. Combined Insurance Reports that Single Working Women's Week is a Good Time for Annual Review of Insurance Coverage
4. CVT Announces That FDA Continues to Review Ranexa(R) Applications
5. Abbott to Preview New CELL-DYN(R) Emerald(TM) Hematology Instrument
6. Rising Medical Solutions, Inc. Expands Its California Managed Care Services to Include Utilization Review Program
7. ACS Bowers Certified to Provide Utilization Review for State Medicaid Agencies
8. Pediatrics review of underage drinking prevention programs led by Iowa State researcher
9. LCA-Vision Provides Business Update and Market Review
10. 2008 Mitchell Medical Industry Conference Previews 100 Percent Paperless Auto Medical Claim Solution
11. American Scientific Resources, Inc. Discloses Reviewed Financials
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Quorum Review IRB Appoints Michael Malafronte Director of Quality and Document Administration
(Date:3/28/2017)... ... March 28, 2017 , ... ... state legislatures and Congress to protect parental rights and civil liberties, and to ... in America. , The demonstration coincides with a press conference taking place Friday ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... management software and services, is proud to announce it has joined the National ... association representing the interests of chronically ill, disabled, and dying Americans of all ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... announces today that the University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® ... Western Pennsylvania. , The program, developed in association with efforts by the American ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... laboratory instruments are critical to ensuring high-quality results and maintaining GMP and USP ... of Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... , ... March 28, 2017 , ... With less than ... acne, access to quality care can be limited while the desire to conquer breakouts ... customized prescription acne care for every customer online, today released its inaugural survey on ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 2017 The National University of Singapore ... analytics company, signed a Memorandum of Understanding (MOU) ... in the region. Under this ... and Technology (BIGHEART) at NUS and Holmusk will ... to healthcare IT and medical device development. These ...
(Date:3/27/2017)... 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology ... toxicology and efficacy studies. The company is harnessing the ... protein, MAGE A, in an effort to find a ... After 4 weeks of treatment in transgenic mice, ... toxicity in a full toxicology report of various organs. ...
(Date:3/27/2017)... March 27, 2017  Sanderling Ventures, portfolio company, ... a division of Johnson & Johnson. Torax manufactures and ... treatment of gastro-esophageal reflux disease (GERD). The LINK ... technology and the procedure is currently available in ... Torax Medical was founded by Sanderling Ventures, Mayo ...
Breaking Medicine Technology: